Clinical Trial Update: Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial [Phase 3]

View source ↗

Summary

A phase 3 randomized, placebo-controlled cross-over trial evaluating milnacipran for neurocognition, pain, and fatigue in fibromyalgia; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Milnacipran (milnacipran)

Snippet

Sponsor: Duke University | Conditions: Fibromyalgia, Neurocognition | Phase 3 | Status: COMPLETED | Results posted: 2014-08-29